Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Front Immunol ; 9: 1471, 2018.
Article in English | MEDLINE | ID: mdl-30034389

ABSTRACT

Antigen determinants (epitopes) are recognized by the combining sites (paratopes) of B and T cell antigen receptors (BCR/TCR), which again express clone-specific epitopes (idiotopes) that can be recognized by BCR/TCR not only of genetically different donors but also within the autologous immune system. While xenogeneic and allogeneic anti-idiotypic BCR/TCR are broadly cross-reactive, only autologous anti-idiotypes are truly specific and of functional regulatory relevance within a particular immune system. Autologous BCR/TCR idiotopes are (a) somatically created at the third complementarity-determining regions, (b) through mutations introduced into BCRs during adaptive immune responses, and (c) through the conformational impact of both. As these idiotypic characters have no genomic counterparts they have to be regarded as antigen receptor-intrinsic nonself-portions. Although foreign, however, they are per se non-immunogenic, but in conjunction with immunogenicity- and adjuvanticity-providing antigen-induced immune responses, they induce abating regulatory idiotypic chain reactions. The dualistic nature of antigen receptors of seeing antigens (self and nonself alike) and being nonself at the same time has far reaching consequences for an understanding of the regulation of adaptive immune responses.

2.
Science ; 355(6326): 704-705, 2017 02 17.
Article in English | MEDLINE | ID: mdl-28209867
3.
Crit Rev Immunol ; 36(1): 13-56, 2016.
Article in English | MEDLINE | ID: mdl-27480901

ABSTRACT

The clone-specific or idiotypic characters of B as well as T cell antigen receptors (BCRs/TCRs) are associated with (1) the third-complementarity-determining regions (CDR3s) that are created during V(D)J recombination (they scarcely occur in antibody light chains) and (2) BCR idiotopes created by somatic hypermutations (SHMs) during immune responses. Therefore, BCR/TCR idiotypic sites are antigen receptor-intrinsic Non-Self (AgR-iNS) portions that fulfill two tasks: serving as a crucial component of the epitope-binding paratope and serving as target sites for anti-idiotypic BCR/TCR paratopes of other anti-Non-Self clones that are contained in both normal repertoires. The antigen-induced immune response is thus directed not only toward the environmental stimulus but also against the AgR-iNS portions of the directly and further activated clones that form a subsiding idiotypic cascade. These idiotypic chain reactions form a completely integrated idiotypic control circuit among B and T cells which contains all regulatory T and B cells. However, this circuit cannot be viewed as a network of fixed interacting nodes but rather uses the genetic Self as reference. Hence, AgR-iNS offers a mechanistic understanding of regulatory lymphocyte-mediated idiotypic control of adaptive immune responses and reconciles clonal selection and idiotypic network theories hitherto believed to be incompatible.


Subject(s)
Adaptive Immunity/immunology , Lymphocytes/immunology , Receptors, Antigen, B-Cell/immunology , Receptors, Antigen, T-Cell/immunology , Animals , Humans , Lymphocyte Activation/immunology
4.
Front Immunol ; 5: 385, 2014.
Article in English | MEDLINE | ID: mdl-25157256

ABSTRACT

The diversity of the third complementarity determining region of the IgH chain is constrained by natural selection of immunoglobulin diversity (DH) sequence. To test the functional significance of this constraint in the context of thymus-dependent (TD) immune responses, we immunized BALB/c mice with WT or altered DH sequence with 2-phenyloxazolone-coupled chicken serum albumin (phOx-CSA). We chose this antigen because studies of the humoral immune response to the hapten phOx were instrumental in the development of the current theoretical framework on which our understanding of the forces driving TD responses is based. To allow direct comparison, we used the classic approach of generating monoclonal Ab (mAb) from various stages of the immune response to phOx to assess the effect of changing the sequence of the DH on clonal expansion, class switching, and affinity maturation, which are hallmarks of TD responses. Compared to WT, TD-induced humoral IgM as well as IgG antibody production in the D-altered ΔD-DµFS and ΔD-iD strains were significantly reduced. An increased prevalence of IgM-producing hybridomas from late primary, secondary, and tertiary memory responses suggested either impaired class switch recombination (CSR) or impaired clonal expansion of class switched B cells with phOx reactivity. Neither of the D-altered strains demonstrated the restriction in the VH/VL repertoire, the elimination of VH1 family-encoded antibodies, the focusing of the distribution of CDR-H3 lengths, or the selection for the normally dominant Ox1 clonotype, which all are hallmarks of the anti-phOx response in WT mice. These changes in clonal selection and expansion, as well as CSR indicate that the genetic constitution of the DH locus, which has been selected by evolution, can strongly influence the functional outcome of a TD humoral response.

5.
Cancer Immunol Immunother ; 62(3): 411-21, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22940887

ABSTRACT

A disintegrin and metalloproteinase 17 (ADAM17) is significantly upregulated not only in malignant cells but also in the pro-inflammatory microenvironment of breast cancer. There, ADAM17 is critically involved in the processing of tumor-promoting proteins. Therefore, ADAM17 appears to be an attractive therapeutic target to address not only tumor cells but also the tumor-promoting environment. In a previous study, we generated a monoclonal anti-ADAM17 antibody (A300E). Although showing no complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity, the antibody was rapidly internalized by ADAM17-expressing cells and was able to transport a conjugated toxin into target cells. As a result, doxorubicin-coupled A300E or Pseudomonas exotoxin A-loaded A300E was able to kill ADAM17-expressing cells. This effect was strictly dependent on the presence of ADAM17 on the surface of target cells. As a proof of principle, both immunotoxins killed MDA-MB-231 breast cancer cells in an ADAM17-dependent manner. These data suggest that the use of anti-ADAM17 monoclonal antibodies as a carrier might be a promising new strategy for selective anti-cancer drug delivery.


Subject(s)
ADAM Proteins/immunology , Antibiotics, Antineoplastic/administration & dosage , Breast Neoplasms/therapy , Doxorubicin/administration & dosage , Immunotoxins/therapeutic use , ADAM Proteins/metabolism , ADAM17 Protein , Antibodies, Monoclonal/therapeutic use , Antibody-Dependent Cell Cytotoxicity , Breast Neoplasms/metabolism , Cell Membrane/metabolism , Cell Proliferation/drug effects , Complement System Proteins/immunology , Female , Humans , Molecular Targeted Therapy
6.
Eur J Immunol ; 42(4): 1016-29, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22531925

ABSTRACT

Antigen affinity is commonly viewed as the driving force behind the selection for dominant clonotypes that can occur during the T-cell-dependent processes of class switch recombination (CSR) and immune maturation. To test this view, we analyzed the variable gene repertoires of natural monoclonal antibodies to the hapten 2-phenyloxazolone (phOx) as well as those generated after phOx protein carrier-induced thymus-dependent or Ficoll-induced thymus-independent antigen stimulation. In contrast to expectations, the extent of IgM heterogeneity proved similar and many IgM from these three populations exhibited similar or even greater affinities than the classic Ox1 clonotype that dominates only after CSR among primary and memory IgG. The population of clones that were selected during CSR exhibited a reduced VH/VL repertoire that was enriched for variable domains with shorter and more uniform CDR-H3 lengths and almost completely stripped of variable domains encoded by the large VH1 family. Thus, contrary to the current paradigm, T-cell-dependent clonal selection during CSR appeared to select for VH family and CDR-H3 loop content even when the affinity provided by alternative clones exhibited similar to increased affinity for antigen.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/immunology , Immunoglobulin Class Switching/immunology , Receptors, Antigen, B-Cell/immunology , T-Lymphocytes/immunology , Animals , Antibodies, Monoclonal, Murine-Derived/genetics , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Female , Haptens/immunology , Haptens/pharmacology , Immunoglobulin Class Switching/drug effects , Immunoglobulin Class Switching/genetics , Immunoglobulin G/genetics , Immunoglobulin G/immunology , Immunoglobulin M/genetics , Immunoglobulin M/immunology , Immunologic Memory/drug effects , Immunologic Memory/genetics , Immunologic Memory/immunology , Mice , Mice, Inbred BALB C , Orexin Receptors , Oxazoles/immunology , Oxazoles/pharmacology , Receptors, Antigen, B-Cell/genetics , Receptors, Neuropeptide/genetics , Receptors, Neuropeptide/immunology
7.
Autoimmun Rev ; 8(5): 394-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19135180

ABSTRACT

The ontogenetic development of both the immune and the nervous system entirely depend on external environmental signals that induce a lifelong learning process. The resulting collective immunological knowledge about the external world is transmitted in an epi-genetic fashion to the offspring, but only from the maternal and not the paternal side, with maternal IgG as the main transgenerational vector. As products of thymus-dependent responses, maternal IgG have undergone immune maturation by somatic hypermutations and are, therefore, acquired immunological phenotypes representing a great deal of the mother's immunological experience. During a limited neonatal imprinting period, maternal antibodies induce T cell-dependent idiotypic responses. These exert up to life-long determinative influences which may even be dominant over seemingly genetic predispositions. Such long-term immunological imprinting effects can be detected as (a) selection of the adult T and B cell repertoires, (b) anti-microbial protection by antigen-reactive antibodies (idiotypes) and anti-idiotypes, (c) allergen-specific suppression of IgE responsiveness by allergen-reactive IgG idiotype or corresponding anti-idiotype and (d) induction of autoimmune diseases by maternally-derived autoantibodies. Hence, immunological imprinting by maternal IgG antibodies will mostly be beneficial, but in case of autoantibodies can also be a burden for the initial development of the nascent immune system.


Subject(s)
Atherosclerosis/immunology , Hypersensitivity/immunology , Immunity, Maternally-Acquired , Neoplasms/immunology , Virus Diseases/immunology , Animals , Atherosclerosis/blood , Atherosclerosis/congenital , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Epitopes/immunology , Female , Humans , Hypersensitivity/blood , Hypersensitivity/congenital , Immunoglobulins/blood , Neoplasms/blood , Neoplasms/congenital , Placental Circulation/immunology , Pregnancy , T-Cell Antigen Receptor Specificity/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Virus Diseases/blood , Virus Diseases/congenital
8.
Mol Immunol ; 45(10): 2847-60, 2008 May.
Article in English | MEDLINE | ID: mdl-18329101

ABSTRACT

Thymus-independent type 2 (TI-2) antigens occasionally induce long-lasting IgM memory, but do not prime for typical secondary IgG responses. However, contrary to current understanding, we detected several TI-2-induced long-term memory effects in subsequent thymus-dependent (TD) responses to the hapten 2-phenyloxazolone coupled to a protein carrier. The early primary TD response, even 3 months after TI-2 immunization, included non-mutated IgM as well as IgG antibodies exhibiting higher affinities than the Ox1 idiotype which dominates and has highest affinity in sole TD responses. The secondary exclusive IgG response 8 weeks later contained major hitherto non-observed clones. Somatic hypermutation on the normally dominant V(H)Ox1 gene was largely silenced while the associated VkappaOx1 exhibited the classical affinity-enhancing mutations, thus suggesting a separate regulation of this process for V(H) and V(L) genes. Mutations accumulated in genes which normally are rarely or non-expressed or non-mutating. First evidence is presented that receptor revision by V(H) replacement may occur during immune maturation in genetically non-engineered wildtype mice. We conclude that the TI-2 antigen-induced altered selection of TD Ag-inducible clones and its severe gene-specific influence on further somatic mutations and affinity maturation represents a network memory, which we hypothesize to be mediated by anti-idiotypic regulatory T cells.


Subject(s)
Antigens, T-Independent/immunology , Immunoglobulin G/immunology , Immunologic Memory/immunology , Amino Acid Sequence , Animals , Antibodies/immunology , Antibody Affinity/immunology , Clone Cells , Cross-Priming/immunology , Female , Immunization , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Mice , Mice, Inbred BALB C , Models, Immunological , Molecular Sequence Data , Mutation/genetics , Oxazolone/analogs & derivatives , Oxazolone/immunology , Somatic Hypermutation, Immunoglobulin/genetics , Thymus Gland/immunology , Time Factors
9.
FASEB J ; 18(7): 893-5, 2004 May.
Article in English | MEDLINE | ID: mdl-15033921

ABSTRACT

Tumor necrosis factor (TNF)-alpha converting enzyme (TACE) is responsible for the ectodomain release of various membrane proteins by proteolytic cleavage in close proximity to the cell membrane. Despite the wide spectrum of possible substrates, selective cleavage can be achieved by substrate cross-linking. To explore the underlying mechanism, we studied the TACE-mediated shedding of CD30. Whereas the constitutive release of the soluble ectodomain of CD30 (sCD30) from the lymphoma cell line Karpas 299 was enhanced by most anti-CD30 antibodies, it was inhibited by antibodies Ber-H2 and Ki-4. On the basis of the recognized epitopes, shedding seemed to depend on the availability of the cysteine-rich domains (CRD) 2 and 5 of the CD30 ectodomain. CRD2 and 5 have almost identical amino acid sequences and are localized distant from the TACE-targeted cleavage site. Soluble CD30, the product of this enzyme reaction, did not inhibit, but on the contrary, it stimulated CD30 shedding in a CRD2/5-dependent manner. This process could also be induced by CRD2/5-derived peptides but not by a CRD1-derived control peptide. This example of a product-activation was CD30 selective since other TACE substrates such as TNFR1 or TNF-alpha were not affected. These data suggest that CD30 shedding is stimulated by an elevated local availability of CRD2 or 5, possibly by forming a docking station for the releasing enzyme through substrate aggregation.


Subject(s)
Ki-1 Antigen/chemistry , ADAM Proteins , ADAM17 Protein , Amino Acid Motifs , Amino Acid Sequence , Animals , Antibodies, Monoclonal/pharmacology , COS Cells , Cell Line, Tumor/metabolism , Chlorocebus aethiops , Cysteine/chemistry , Epitopes/immunology , Hodgkin Disease/pathology , Humans , Hydrophobic and Hydrophilic Interactions , Immunoglobulin Fab Fragments/immunology , Ki-1 Antigen/immunology , Ki-1 Antigen/metabolism , Lymphoma, Non-Hodgkin/pathology , Metalloendopeptidases/metabolism , Molecular Sequence Data , Neoplasm Proteins/chemistry , Neoplasm Proteins/immunology , Neoplasm Proteins/metabolism , Peptide Fragments/pharmacology , Protein Structure, Tertiary , Sequence Alignment , Sequence Deletion , Sequence Homology, Amino Acid , Solubility , Structure-Activity Relationship , Substrate Specificity , Transfection
11.
Vaccine ; 21(24): 3428-31, 2003 Jul 28.
Article in English | MEDLINE | ID: mdl-12850353

ABSTRACT

Maternal antibodies (IgG and IgA) not only provide passive protection against microbial infections, but also exert a variety of equally important active, idiotypically-mediated immunoregulatory functions. Since the generation of maternal antibodies depends entirely on the stimulation of the mother's immune system by external mainly thymus-dependent antigens, with long-lived antigen independent plasma cells in the bone marrow, maternal antibodies represent the mother's collective ontogenetic immunological experience. Although their stimulatory potential in mice is restricted to the neonatal imprinting period, maternal antibodies exert a life-long determinative influence which is even dominant over seemingly genetic predispositions. Therefore, the functional impact of maternal IgG antibodies appears phenotypically as a non-genetic inheritance.


Subject(s)
Antibodies/genetics , Oxazolone/analogs & derivatives , Animals , Antibodies, Monoclonal/pharmacology , Female , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Maternal-Fetal Exchange/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred CBA , Ovomucin/immunology , Oxazolone/immunology , Phospholipases A/immunology , Pregnancy
12.
J Biol Chem ; 278(26): 23301-10, 2003 Jun 27.
Article in English | MEDLINE | ID: mdl-12649268

ABSTRACT

Trypanosomes express an enzyme called trans-sialidase (TS), which enables the parasites to transfer sialic acids from the environment onto trypanosomal surface molecules. Here we describe the purification and characterization of two TS forms from the African trypanosome Trypanosoma congolense. The purification of the two TS forms using a combination of anion exchange chromatography, isoelectric focusing, gel filtration, and subsequently, antibody affinity chromatography resulted, in both cases, in the isolation of a 90-kDa monomer on SDS-PAGE, which was identified as trans-sialidase using micro-sequencing. Monoclonal antibody 7/23, which bound and partially inhibited TS activity, was found in both cases to bind to a 90-kDa protein. Both TS forms possessed sialidase and transfer activity, but markedly differed in their activity ratios. The TS form with a high transfer-to-sialidase activity ratio, referred to as TS-form 1, possessed a pI of pH 4-5 and a molecular mass of 350-600 kDa. In contrast, the form with a low transfer-to-sialidase activity ratio, referred to as TS-form 2, exhibited a pI of pH 5-6.5 and a molecular mass of 130-180 kDa. Both TS forms were not significantly inhibited by known sialidase inhibitors and revealed no significant differences in donor and acceptor substrate specificities; however, TS-form 1 utilized various acceptor substrates with a higher catalytic efficiency. Interestingly, glutamic acid-alanine-rich protein, the surface glycoprotein, was co-purified with TS-form 1 suggesting an association between both proteins.


Subject(s)
Neuraminidase/chemistry , Neuraminidase/isolation & purification , Trypanosoma congolense/enzymology , Animals , Antibodies, Monoclonal , Enzyme Inhibitors/pharmacology , Glycoproteins , Immunoblotting , Molecular Sequence Data , Molecular Weight , N-Acetylneuraminic Acid/metabolism , Neuraminidase/metabolism , Sequence Analysis, Protein , Substrate Specificity
13.
Acta Derm Venereol ; 82(4): 245-8, 2002.
Article in English | MEDLINE | ID: mdl-12361126

ABSTRACT

The levels of soluble CD30 in 79 patients with atopic dermatitis were compared with those found in 54 patients with psoriasis and 36 control individuals (no psoriasis, no atopic dermatitis). In relation to the control group, patients with atopic dermatitis were found to exhibit an increased concentration of sCD30 of at least 1.5-fold (p < 0.001). In addition, sCD30 concentrations were shown to correlate with the severity of the disease as measured by the score index for atopic dermatitis and different stages of disease activity, such as acute, subacute, or chronic forms, and localized or generalized distribution of atopic dermatitis. The application of topical glucocorticoid therapy for a period of 2 weeks resulted in a decrease in the level of sCD30 by 46% in 8 patients, especially in the acute, generalized form of atopic dermatitis. Psoriasis patients showed no significant differences in sCD30 levels in relation to the control group. This study demonstrates a correlation between sCD30 concentration and the activity of the disease and therefore suggests sCD30 as a prognostic marker, being superior to predictions from measurements of IgE or eosinophil cationic protein.


Subject(s)
Dermatitis, Atopic/immunology , Ki-1 Antigen/blood , Ribonucleases , Administration, Topical , Adult , Anti-Inflammatory Agents/therapeutic use , Blood Proteins/analysis , Dermatitis, Atopic/diet therapy , Eosinophil Granule Proteins , Female , Glucocorticoids , Humans , Immunoglobulin E/blood , Male , Severity of Illness Index
14.
J Autoimmun ; 18(3): 239-50, 2002 May.
Article in English | MEDLINE | ID: mdl-12126637

ABSTRACT

In primary systemic vasculitis anti endothelial cell autoantibodies (AECA) have been described frequently. They represent a heterogeneous group of autoantibodies whose target antigens are mostly unknown. We tried to find AECA-antigens by a co-operative binding assay with a panel of monoclonal antibodies (mAb) directed to human umbilical vein endothelial cells (HUVEC) and extracellular matrix proteins. The mAb were used to bind antigens from lysate of endothelial cells, and binding of human antibodies to these antigens was measured. mAb directed to Vitronectin (VN) and Fibronectin (FN) resulted in enhanced binding of antibodies in sera from patients with Churg Strauss Syndrome (CSS) and Wegener's Granulomatosis (WG) compared to normal sera. Neither free autoantibodies against VN or FN could be detected nor did the addition of endothelial cell lysate influence the binding activity from the patients' sera. This suggests that preformed VN and FN-containing immune complexes (IC) are present in the patient sera. The amount of IC was decreased by incubation with HUVEC, demonstrating that these IC can bind to endothelial cells. However, their involvement in the pathogenesis of the disease is not clearly defined. Our data suggest that there are preformed IC present in sera of patients with CSS and WG that contain VN and FN and bind to endothelial cells.


Subject(s)
Antigen-Antibody Complex/blood , Churg-Strauss Syndrome/immunology , Fibronectins/immunology , Granulomatosis with Polyangiitis/immunology , Vitronectin/immunology , Antibodies, Monoclonal/metabolism , Antigen-Antibody Complex/chemistry , Autoantibodies/blood , Autoantigens/blood , Binding, Competitive , Case-Control Studies , Cells, Cultured , Endothelium, Vascular/immunology , Fibronectins/blood , Humans , Immunosorbent Techniques , In Vitro Techniques , Molecular Weight , Solubility , Vitronectin/blood
16.
Adv Immunol ; 80: 203-41, 2002.
Article in English | MEDLINE | ID: mdl-12078482

ABSTRACT

Clonal interactions of B cells by idiotope-specific mutual recognition of their antigen receptors with the participation of T cells were assumed to form a web of unknown density, referred to as the idiotypic network. Although these clonal connections were proposed to fulfill important internal regulatory functions, their biological significance, especially in relation to antigen-induced immune responses, remained a mystery. In view of this, we postulate that the basic function of the idiotypic internal connection between B and T cell antigen receptors is to transform antigen-induced cellular activations, by idiotypic crossreactivity, into the regulation of cell clones with different antigen specificities. This process leads not only to the suppression of major clones but also to the activation of minor ones. The latter activating property may allow the generalization of single antigenic experiences, so that the immune system in its entirety benefits in its battle against environmental microbes. Such idiotypic clonal interactions are particularly effective in early ontogeny. During a short neonatal imprinting period, maternal immunological knowledge in the form of somatically mutated, high-affinity IgG antibodies, acquired through a continuous encounter with external antigens, guides the initial ontogenetic development of the immune system and so exerts long-lasting transgenerational advantageous effects in the offspring.


Subject(s)
Antibodies, Anti-Idiotypic/immunology , B-Lymphocytes/immunology , T-Lymphocytes/immunology , Animals , Cell Communication , Humans , Immune System/physiology , Immunity, Maternally-Acquired
17.
Int J Cancer ; 98(2): 210-5, 2002 Mar 10.
Article in English | MEDLINE | ID: mdl-11857410

ABSTRACT

CD30 is selectively expressed on the tumor cells of a variety of malignant disorders of the immune system and can therefore be used as a target for an anti-CD30 antibody-based immunotherapy. However, CD30 is cleaved at the cell surface by tumor necrosis factor-alpha converting enzyme (TACE). This metalloproteinase releases the soluble ectodomain of CD30 (sCD30), which is able to neutralize immunotherapeutic agents before these reach their target cells. Such constitutive CD30 cleavage is enhanced after binding of most anti-CD30 antibodies, leading to a downregulation of CD30 and an increase of sCD30 in the cell environment. Here, we demonstrate that CD30 shedding from the cell line Karpas 299 could effectively be blocked by the hydroxamic acid-based metalloproteinase inhibitors BB-3644 (IC50 = 180 nM), BB-2116 (IC50 = 230 nM), BB-94 (batimastat, IC50 = 230 nM) and BB-2516 (marimastat, IC50 = 1 microM). This inhibition reduced the concentration of sCD30 in the cell environment to the background level, prolonged the persistence of the anti-CD30 antibody Ki-3 on Karpas 299 cells and favored its internalization. Moreover, a nontoxic concentration of the inhibitor BB-3644 significantly increased the cytotoxic activity of the anti-CD30 ricin A-chain immunotoxin Ki-3.dgA towards the CD30(+) Hodgkin-derived cell line L540. Hence, the metalloproteinase inhibitor BB-3644 may be a promising compound to improve the immunotherapy of CD30(+) malignancies.


Subject(s)
Aminopyridines/pharmacology , Antibodies, Monoclonal/metabolism , Hydroxamic Acids/pharmacology , Immunotoxins/pharmacology , Ki-1 Antigen/immunology , Metalloendopeptidases/antagonists & inhibitors , Protease Inhibitors/pharmacology , Aminopyridines/chemistry , Antibodies, Monoclonal/immunology , Cell Survival , Dose-Response Relationship, Drug , Endocytosis , Humans , Hydroxamic Acids/chemistry , Ki-1 Antigen/metabolism , Kinetics , Lymphoma/metabolism , Lymphoma/therapy , Lymphoma, Large-Cell, Anaplastic/metabolism , Lymphoma, Large-Cell, Anaplastic/therapy , Protease Inhibitors/chemistry , Tumor Cells, Cultured
18.
Eur J Immunol ; 32(11): 3133-41, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12555658

ABSTRACT

IgE is an important trigger in allergy and asthma, diseases whose development is suggested to depend on an initial sensitization in early life. While induction of murine IgE responses requires both a genetically based IgE high responder phenotype and defined experimental conditions, maternally transferred IgG can override these prerequisites and suppress IgE formation in an allergen-specific manner. Here, we show that maternally transferred monoclonal IgG, irrespective of their subclass and recognized epitopes, induce IgE unresponsiveness, which is effective for parenteral immunization with bee venom phospholipase A2 as well as for airway-immunization with nebulized ovomucoid-containing ovalbumin. This IgE suppression is detectable in the offspring during the first 4 months of life, but not thereafter and not in the dams. However, when the initial immunization at an age of 3 or 4 months was followed by further application of both allergens via their respective routes, IgE suppression persisted up to an age of more than one year. If applicable to man, these findings may allow the development of a new strategy for the prevention of allergy and asthma by maternally transferred or neonatally injected allergen-specific mAb in combination with natural or prophylactic exposure to the respective allergens during early childhood.


Subject(s)
Allergens/immunology , Antibodies, Monoclonal/immunology , Immune Tolerance , Immunity, Maternally-Acquired , Immunoglobulin E/biosynthesis , Immunoglobulin G/immunology , Age Factors , Animals , Bee Venoms/immunology , Female , Mice , Mice, Inbred BALB C , Mice, Inbred CBA , Ovomucin/immunology , Phospholipases A/immunology , Phospholipases A2 , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...